Inspire Medical Systems (NYSE:INSP) Director Mudit K. Jain sold 500 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $68.47, for a total transaction of $34,235.00. Following the transaction, the director now directly owns 6,097 shares of the company’s stock, valued at approximately $417,461.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Inspire Medical Systems stock traded up $0.05 during trading hours on Wednesday, hitting $72.27. 204,592 shares of the company traded hands, compared to its average volume of 298,025. The firm has a market cap of $1.79 billion, a P/E ratio of -48.18 and a beta of 1.27. The company has a quick ratio of 13.05, a current ratio of 13.42 and a debt-to-equity ratio of 0.17. The firm’s 50-day simple moving average is $62.36 and its two-hundred day simple moving average is $62.07. Inspire Medical Systems has a 1-year low of $35.43 and a 1-year high of $74.41.
Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Tuesday, November 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.43) by $0.09. The company had revenue of $20.86 million for the quarter, compared to analysts’ expectations of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. The business’s revenue was up 59.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.22) EPS. On average, equities research analysts predict that Inspire Medical Systems will post -1.46 earnings per share for the current year.
Several institutional investors and hedge funds have recently made changes to their positions in the business. Strs Ohio boosted its holdings in shares of Inspire Medical Systems by 8.7% during the second quarter. Strs Ohio now owns 2,500 shares of the company’s stock worth $151,000 after purchasing an additional 200 shares during the period. Advisory Services Network LLC raised its position in Inspire Medical Systems by 24.6% during the second quarter. Advisory Services Network LLC now owns 1,395 shares of the company’s stock valued at $85,000 after acquiring an additional 275 shares in the last quarter. California State Teachers Retirement System raised its position in Inspire Medical Systems by 1.8% during the third quarter. California State Teachers Retirement System now owns 20,887 shares of the company’s stock valued at $1,275,000 after acquiring an additional 377 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Inspire Medical Systems by 293.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 637 shares of the company’s stock valued at $39,000 after acquiring an additional 475 shares in the last quarter. Finally, Commonwealth Equity Services LLC raised its position in Inspire Medical Systems by 10.4% during the third quarter. Commonwealth Equity Services LLC now owns 7,023 shares of the company’s stock valued at $428,000 after acquiring an additional 660 shares in the last quarter. Institutional investors own 89.74% of the company’s stock.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Recommended Story: S&P/ASX 200 Index
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.